Health System

New Rx, generics, and OTC

Seven out of 10 prescribers use e-prescribing, and virtually all pharmacies are now equipped to receive them.

FDA has approved empagliflozin (Jardiance, Boehringer Ingelheim Pharmceuticals) as another option for adult patients with type 2 diabetes.

A young PharmD takes on a repetitive process and turns it into a mobile app.

Here's what pharmacists were reading, talking, posting, and tweeting about throughout July 2014.

FDA gives the nod to Purdue Pharma's Targiniq ER.

For newly fledged pharmacists, a few solid tips on how to honor your patients, your profession, and yourselves.

McKesson's new Adherence Performance reporting solution will provide actionable data to identify patients more quickly than pharmacies can do using a manual method.

Colchicine therapy, an effective anti-inflammatory agent for gout, is a promising treatment for preventing recurrent pericarditis. However, some patients have discontinued its use because of gastrointestinal intolerance, according to a report published online for the American Journal of Health-System Pharmacy, which will appear in the August 1 edition.

Patients who received the combo along with statin therapy did not experience higher rates of prevention of major vascular events compared with those taking placebo and statins.

The Drug Enforcement Administration (DEA) ruled this week that the pain reliever tramadol is now classified as a Schedule IV controlled substance (CS).

Written by a pharmacist who has endured through thick and through thin, these 10 tips remind pharmacy professionals that they have plenty to take pride in.

As specialty pharmaceuticals consume more of the healthcare dollar, the role of managed care pharmacy will be critical.

Go ahead. Blame Obamacare. It won't make any difference.

Industry and academe collaborate on opportunities for young people to explore the range of careers in pharmacy.

Electronic prescribing of controlled substances isn't much of an improvement over previous practice.

Letters, e-mails, posts, and comments from Drug Topics readers.

New Rx, generics, OTC, and devices for pharmacists.

Two trials involving 100 totally blind individuals with circadian rhythm sleep disorders established the efficacy of the new product.

Specialty pharmacy is big and getting bigger. Some even call it a gold rush. Here are tips for those who'd like a piece of the action.

Available data indicated "serious risks associated with the use of aspirin, including increased risk of bleeding in the stomach and brain."

The Supplemental Bulletin expands upon previous guidance, focusing particularly on disease funds and legitimate copay waivers for prescribed medications.

The words might as well be tattooed on our foreheads: "I probably know the answer. I don't even charge."

A new survey indicates that pharmacists, nurses, and other practitioners believe IV insulin and anticoagulants should be considered the medications that can cause the most harm when used improperly.

More than 80% of healthcare employees dilute certain IV push medications, which is not always necessary, according to a new survey conducted by the Institute for Safe Medication Practices (ISMP).

A new law that will allow pharmacists in Kansas to create collaborative agreements with physicians will take effect in July.

The Institute for Safe Medication Practices (ISMP) recently warned about alphanumeric symbol mixups, particularly in handwritten scripts, which have led to medical errors.

Electronic prescribing was supposed to be the savior of pharmacy. Things haven’t quite worked out that way.

Costly treatments are expected to drive unprecedented growth in U.S. drug spending over the next two years. Some analysts say that’s not good news for consumers or most pharmacists.